Managing Diabetes in Special Populations
Managing Type 2 Diabetes in Special Populations: Patient-Centered Treatment to Improve Outcomes
To enable primary care clinicians to integrate emerging antihyperglycemic agents into culturally-competent, patient-centered treatment strategies in the management of type 2 diabetes.
Family physicians, other primary care physicians, and those with an interested in diabetes care.
- Employ culturally competent, patient-centered treatment strategies to manage type 2 diabetes in elderly, overweight/obese, or Latino/Latina patients.
- Employ strategies to overcome barriers that traditionally inhibit the initiation of care in these populations.
- Design safe and effective treatment strategies that are tailored to the individual needs of patients in these populations.
- Integrate emerging antihyperglycemic agents into patient-centered type 2 diabetes management plans for persons in these populations.
Disclosures of Relevant Financial Relationships
In accordance with the ACCME Standards for Commercial Support and with the policies of the American Academy of Family Physicians, NJAFP policy requires that all persons that affect the content of this CME activity disclose to the CME providers financial relationships they or their spouse/significant other have with either the commercial supporter of this activity or with the manufacturers of any products they are referencing in this enduring material. The following individuals have provided disclosure information:
|Name||Manufacturer with whome there is a Financial Relationship||Type of Relationship|
|Theresa J. Barrett, PhD||NA||No Relationships|
|Jack Douglass||NA||No Relationships|
Charles A. Goldthwaite, Jr., PhD.
|Faculty||Position||Manufacturer with whom there is a Financial Relationship||Type of Relationship|
|Ildiko Lingvay, MD, MPH, MSCS||Associate Professor; Department of Internal Medicine/ Division of Endocrinology. Department of Clinical Sciences; University of Texas Southwestern Medical Center; Dallas, TX|
|Jerry McCauley, MD, MPH, FACP||Robert Capizzi Professor of Medicine; Director, Division of Nephrology Sidney Kimmel Medical College Thomas Jefferson University Hospital Philadelphia, PA||NA||No Relationships|
|Everett Schlam, MD||Assistant Director|
Mountainside Family Practice Residency Program; Clinical Assistant Professor, Department of Family Medicine UMDNJ – New Jersey Medical School, Verona, NJ
|Penny Tenzer, MD, FAAFP||Professor of Clinical Family Medicine|
Vice Chair of Academic Affairs
Director of CME and Medical Education; Chief of Service, Family Medicine, University of Miami Hospital; University of Miami Miller School of Medicine; Miami, FL
Lauren Curruth, MD the reviewer has no relevant financial relationships.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
This program is supported by an educational grant from Janssen pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.
DATE OF RELEASE AND TERMINATION DATE
The Date of Release for this activity is: June 1, 2016
The Terminate Date for this activity is: May 31, 2017
- 2.00 AAFP Prescribed
- 2.00 Attendance